[Therapeutic principles in gastroesophageal reflux].
Gastroesophageal reflux is a common disease. Its chronic course, even if mild, is sometimes complicated by erosive oesophagitis. Drug therapy acts against gastric acidity and motility disorders. Treatment of gastroesophageal reflux disease has three aims: improvement of symptoms and quality of life, healing erosive lesions and prevention of symptomatic and endoscopic relapses. Non-drug measures are always useful, even if their efficacy is not well established. Initial therapy of a symptomatic reflux or mild oesophagitis is most of the time effective (antacids, prokinetics, H2 receptor antagonists). Proton-pump inhibitors are also effective in healing and preventing severe oesophagitis. Questions about long-term treatment adverse events with powerful acid inhibitors, such as hypergastrinemia and the risk of gastric carcinoid tumours seem to be resolved. Studies are requested to define the optimal long-term maintenance treatment with cisapride, H2 receptor antagonists or proton-pump inhibitors at low doses in prevention of symptomatic and mild oesophagitis relapses.
Chassany
O
O
Service médical d'accueil, hôpital Lariboisière, Paris, France.
Elkharrat
D
D
Bergmann
J F
JF
Segrestaa
J M
JM
D004942:Esophagitis, Peptic / Q000188:drug therapy / Q000628:therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D012008:Recurrence
Principes thérapeutiques du reflux gastroesophagien.